A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute.

@article{Didomenico2011,
  title={A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute.},
  author={Lawrence A Didomenico and Arnold Robert Landsman and Kenneth J Emch and Adam Scott Landsman},
  journal={Wounds : a compendium of clinical research and practice},
  year={2011},
  volume={23 7},
  pages={184-9}
}
UNLABELLED Background. It was hypothesized that the rate of wound closure and the number of grafts required will be the same when treating diabetic foot ulcers with TheraSkin®, a cryopreserved split-thickness skin allograft (SSA), as compared to Apligraft®, a bioengineered skin substitute (BSS). METHODS A prospective study using sequentially enrolled patients seen in a large podiatric practice encompassing multiple locations was conducted. Patients were sequentially enrolled and treated with… CONTINUE READING
7 Citations
6 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-6 of 6 references

Similar Papers

Loading similar papers…